Literature DB >> 16722625

Novel peptidomimetic cysteine protease inhibitors as potential antimalarial agents.

Nicola Micale1, Alan P Kozikowski, Roberta Ettari, Silvana Grasso, Maria Zappalà, Jong-Jin Jeong, Ajay Kumar, Manjit Hanspal, Athar H Chishti.   

Abstract

The synthesis of a new class of peptidomimetics 1a-j, based on a 1,4-benzodiazepine scaffold and on a C-terminal aspartyl aldehyde building block, is described. Compounds 1a-j provided significant inhibitory activity against falcipains 2A and 2B (FP-2A and FP-2B), two cysteine proteases from Plasmodium falciparum.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16722625     DOI: 10.1021/jm060405f

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Inhibition of Plasmodium falciparum oocyst production by membrane-permeant cysteine protease inhibitor E64d.

Authors:  S Eksi; B Czesny; G-J van Gemert; R W Sauerwein; W Eling; K C Williamson
Journal:  Antimicrob Agents Chemother       Date:  2006-12-18       Impact factor: 5.191

2.  Copper-catalyzed ligand-free amidation of aryl iodides and amino acid amides to synthesize C3-(Z)-1H-benzo[e][1,4]diazepin-2(3H)-ones.

Authors:  Xiao Hu; Yi Dong; Gang Liu
Journal:  Mol Divers       Date:  2015-06-07       Impact factor: 2.943

3.  Novel anti-plasmodial hits identified by virtual screening of the ZINC database.

Authors:  Grace Mugumbate; Ana S Newton; Philip J Rosenthal; Jiri Gut; Rui Moreira; Kelly Chibale; Rita C Guedes
Journal:  J Comput Aided Mol Des       Date:  2013-10-25       Impact factor: 3.686

4.  Plasmodium yoelii inhibitor of cysteine proteases is exported to exomembrane structures and interacts with yoelipain-2 during asexual blood-stage development.

Authors:  Ying Pei; Jessica L Miller; Scott E Lindner; Ashley M Vaughan; Motomi Torii; Stefan H I Kappe
Journal:  Cell Microbiol       Date:  2013-03-14       Impact factor: 3.715

5.  Antimalarial activity of thiosemicarbazones and purine derived nitriles.

Authors:  Jeremy P Mallari; Wendyam A Guiguemde; R Kiplin Guy
Journal:  Bioorg Med Chem Lett       Date:  2009-05-05       Impact factor: 2.823

6.  BDA-410: a novel synthetic calpain inhibitor active against blood stage malaria.

Authors:  Xuerong Li; Huiqing Chen; Jong-Jin Jeong; Athar H Chishti
Journal:  Mol Biochem Parasitol       Date:  2007-05-18       Impact factor: 1.759

Review 7.  Isocyanide-based multicomponent reactions towards cyclic constrained peptidomimetics.

Authors:  Gijs Koopmanschap; Eelco Ruijter; Romano Va Orru
Journal:  Beilstein J Org Chem       Date:  2014-03-04       Impact factor: 2.883

8.  In silico Guided Drug Repurposing: Discovery of New Competitive and Non-competitive Inhibitors of Falcipain-2.

Authors:  Lucas N Alberca; Sara R Chuguransky; Cora L Álvarez; Alan Talevi; Emir Salas-Sarduy
Journal:  Front Chem       Date:  2019-08-06       Impact factor: 5.221

9.  Identification of Tight-Binding Plasmepsin II and Falcipain 2 Inhibitors in Aqueous Extracts of Marine Invertebrates by the Combination of Enzymatic and Interaction-Based Assays.

Authors:  Emir Salas-Sarduy; Yasel Guerra; Giovanni Covaleda Cortés; Francesc Xavier Avilés; María A Chávez Planes
Journal:  Mar Drugs       Date:  2017-04-21       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.